Earnings Estimates


Target Price Summary
Current Trading Price: $ 4.06
Mean: $ 6.11
Median: $ 5.00
High: $ 13.00
Low: $ 4.00

* 11 analysts reported target price for Idenix Pharmaceuticals, Inc.

 
Current Recommendations
Consensus Rating: OUTPERFORM (12 total analysts)

Consensus Rating
 
Analyst Estimates
Earnings Per Share Current Quarter
Jun 2013 		Next Quarter
Sep 2013 		Current Year
Dec 2013 		Next Year
Dec 2014
Consensus $ -0.22 $ -0.23 $ -0.88 $ -0.87
High $ -0.17 $ -0.17 $ -0.68 $ -0.20
Low $ -0.29 $ -0.32 $ -1.20 $ -1.32
P/E N/A N/A N/A N/A
Year Ago EPS $ -0.23 $ 0.03 $ -0.27 $ -0.88
Number of Analyst(s) 10 10 14 12
Revision(s) Up
Last 30 Days		 0 0 0 1
Revision(s) Down
Last 30 Days		 5 4 11 8
 
Estimate Analysis

Disclaimer: Average earnings estimates are calculated by FactSet based on their earnings projections made by the analysts who cover Idenix Pharmaceuticals, Inc. Please note that any opinions, estimates or forecasts regarding Idenix Pharmaceuticals, Inc.'s performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of Idenix Pharmaceuticals, Inc. or its management. Idenix Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.